TokenPost·
AbbVie Raises Full-Year Guidance as Non-GAAP EPS Beats Estimates
Third-quarter revenue reached $17.4 billion, up 10.3% year over year, while the immunology portfolio generated $9.165 billion in global net revenue.
More news
- TokenPostJapan’s FSA Publishes a 609-Page Survey of Global Financial Systems
- TokenPostNvidia Shares Fall 3.3%, Market Value at $4.98 Trillion
- Crypto BriefingBank of America says big tech bonds offer more opportunity than stocks
- TokenPostCrypto-Linked Stocks Fall at U.S. Open as Coinbase Drops 12.46%
- TokenPostRobinhood Q3 2026 Net Revenue Rises 12% As Crypto Transaction-Based Revenue Falls 55%
- TokenPostHashKey RWA Launches First hToken Security With USDT Subscriptions